PGI39 Budegt Impact Analysis of HCV Therapy Cost After Boceprevir Addition to Standard Therapeutic Regime

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.788
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search